Product Images Reblozyl

This appears to be a medication label containing dosage instructions, manufacturer information, and expiration date. The medication is called "WCSSTATIN" and is injected to protect from light. The label also shows the dosage of "25 my/vial" and that it is manufactured by "Celgene Corporation". The lot number is "EXP VL71101.002".*

Reblozyl® (luspatercept-aamt) is a medication available as an injection in a single-dose vial. It is used for subcutaneous use only and needs to be reconstituted with sterile water for injection USP before administration. The medication is manufactured by Bristol Myers Squibb Company and registered under US License No. 2252. It is also registered as a trademark of Colgoe Corporation, a subsidiary of Bristol Myers Squibb Company. The dosage information and potency details are not available in the given text.*

NOCSTRTIN and Reblozyf are two different injectable drugs containing luspatercept-aamt and are used for subcutaneous administration with a one size dose vial for individuals with certain blood disorders. They are marketed by Bristol Myers Squibb. The exact dosage and administration details can be found on the packaging of the product.*

Reblozyl (luspatercept-aamt) is an injection drug used for subcutaneous administration after reconstitution with sterile water for injection USP. It comes in a kit containing a single-use vial. Unfortunately, some parts of the text are not readable due to errors.*